Insider Shareholders with Direct Ownership of Spero Therapeutics, Inc. (SPRO)
This section provides a comprehensive overview of the insiders with direct ownership of Spero Therapeutics, Inc. (SPRO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Spero Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Sath Shukla
CEO & President |
1,273,539 | 132,730 | 1,140,809 $1.36 Million | 14 |
Aug 27, 2024
Reduced 0.24%
|
|
Kamal Hamed
Chief Medical Officer |
855,688 | 67,571 | 788,117 $937,859 | 6 |
Feb 02, 2024
Reduced 3.44%
|
| 816,300 | 123,032 | 759,085 $903,311 | 21 |
Aug 27, 2024
Reduced 0.77%
|
|
|
Timothy Keutzer
Chief Operating Officer |
567,769 | 38,432 | 531,837 $632,886 | 8 |
Aug 27, 2024
Reduced 0.41%
|
|
Tamara L Joseph
Chief Legal Officer |
567,769 | 36,154 | 531,615 $632,621 | 7 |
Feb 02, 2024
Reduced 5.49%
|
|
Esther Rajavelu
CFO & CBO |
419,866 | 40,596 | 379,270 $451,331 | 4 |
Nov 08, 2024
Reduced 4.35%
|
| 55,000 | 0 | 71,454 $85,030 | 3 |
May 29, 2024
Added 21.87%
|
|
|
Cristina Larkin
Chief Operating Officer |
74,081 | 12,000 | 63,581 $75,661 | 4 |
Feb 01, 2022
Added 37.42%
|
|
David A. Melnick
Chief Medical Officer |
62,081 | 0 | 62,081 $73,876 | 2 |
Feb 01, 2022
Added 37.98%
|
| 55,000 | 0 | 55,000 $65,450 | 3 |
May 29, 2024
Added 26.67%
|
|
| 55,000 | 0 | 55,000 $65,450 | 3 |
May 29, 2024
Added 26.67%
|
|
| 55,000 | 0 | 55,000 $65,450 | 3 |
May 29, 2024
Added 26.67%
|
|
| 55,000 | 0 | 55,000 $65,450 | 3 |
May 29, 2024
Added 26.67%
|
|
| 55,000 | 0 | 55,000 $65,450 | 3 |
May 29, 2024
Added 26.67%
|
|
| 55,000 | 0 | 55,000 $65,450 | 3 |
May 29, 2024
Added 26.67%
|